In CRC, the main neoplasia treated with 5-FU, the landscape is too similar, and the high expression of TS is frequently observed in refractory patients to 5-FU treatment; in contrast, diminished TS expression correlates with a better response to chemotherapeutic treatments [32]. The gene discussed is TYMS; the disease is colorectal carcinoma.